Parfait B, Percheron A, Chretien D, Rustin P, Munnich A, Rötig A
Unité de Recherches sur les Handicaps Génétiques de l'Enfant, INSERM U393, Hôpital des Enfants Malades, Paris, France.
Hum Genet. 1997 Dec;101(2):247-50. doi: 10.1007/s004390050625.
Cytochrome c oxidase (COX) deficiency causes a variety of neuromuscular and non-neuromuscular disorders in childhood and adulthood and can theoretically undergo either a nuclear or a mitochondrial (mt) mode of inheritance, making genetic counseling in COX deficiency particularly hazardous. In an attempt to determine the respective roles of mtDNA and nuclear DNA mutations in COX deficiency, we sequenced the three mitochondrially encoded COX subunits (COXI-III) in a series of 18 patients with isolated COX deficiency, especially as COXI-III code for the catalytic site of the enzyme. We failed to detect any deleterious mutations in this series. Moreover, no mtDNA deletion was observed and sequencing of the flanking tRNA genes involved in the maturation of the COX transcripts failed to detect deleterious mutations as well. The present study supports the view that the disease-causing mutations do not lie in the mt genome but, rather, in the nuclear genes encoding either the COX subunits or the proteins involved in assembly of the complex and suggests a recurrent risk of 25% rather than other modes of inheritance in COX deficiencies.
细胞色素c氧化酶(COX)缺乏症在儿童期和成年期会引发多种神经肌肉和非神经肌肉疾病,理论上它可通过核遗传或线粒体(mt)遗传模式进行遗传,这使得COX缺乏症的遗传咨询具有极大风险。为了确定mtDNA和核DNA突变在COX缺乏症中各自的作用,我们对一系列18例孤立性COX缺乏症患者的三个线粒体编码的COX亚基(COX I - III)进行了测序,特别是因为COX I - III编码该酶的催化位点。在这个系列中我们未检测到任何有害突变。此外,未观察到mtDNA缺失,对参与COX转录本成熟的侧翼tRNA基因进行测序也未检测到有害突变。本研究支持这样一种观点,即致病突变不在于mt基因组,而在于编码COX亚基或参与复合物组装的蛋白质的核基因,并表明在COX缺乏症中复发风险为25%,而非其他遗传模式。